medigraphic.com
ISSN 0016-3813 (Print)

2016, Number 3

<< Back Next >>

Gac Med Mex 2016; 152 (3)

P200 parameters in patients with diabetes mellitus type 2 (DM2)

Hernández OH, Aguirre-Manzo L, Ye-Ehuan F, García-Martínez R, Maldonado-Velázquez G

Language: Spanish
References: 62
Page: 313-321
PDF size: 188.97 Kb.


ABSTRACT

Introduction: A complication underserved in diabetic patients is the cognitive deficits that can reach dementia. Studying the association between electrophysiological, neuropsychological, and biochemical measures could provide a breakthrough in the understanding of this phenomenon. Objectives: To compare P200 parameters between subjects with and without diabetes mellitus type 2 and to determine their relationship with biochemical and neuropsychological indicators. Methods: This is an observational, prospective, transversal and analytical study. Seventy-four participants were divided into two groups: 37 with diabetes mellitus type 2, and 37 subjects as controls. P200 latency, amplitude, and rate of rise to somatosensory stimuli were measured and related to the Mini Mental State Examination (MMSE) test and blood glucose and glycosylated hemoglobin. Results: Diabetics showed longer latency (p ‹ 0.042, 1-tail) and lower MMSE score (p ‹ 0.0001) than controls. Negative associations of amplitude and rising rate with glycosylated hemoglobin were observed in patients (p ‹ 0.025); also, between amplitude and blood glucose (p ‹ 0.038, 1-tail) and between MMSE score and time with diabetes mellitus type 2 (p ‹ 0.007). Conclusions: The P200 parameters of the somatosensory system are sensitive to metabolic deterioration of diabetic patients, so its use in monitoring the cognitive state of patients is recommended.


REFERENCES

  1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7.

  2. Danaei G, Finucane MM, Lu Y, et al. Global burden of metabolic risk factors of chronic diseases collaborating group (blood glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.

  3. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB. Association of diabetes mellitus and dementia: the Rotterdam study. Diabetologia. 1996;39:1392-7.

  4. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology. 2004;63:996-1001.

  5. Arvanitakis Z, Wilson RS, Li Y, Aggarwald NT, Bennett DA. Diabetes and its function in different cognitive systems in older individuals without dementia. Diabetes Care. 2006;29:560-5.

  6. Whitmer RA. Type 2 diabetes and the risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep. 2007;7:373-80.

  7. Vijayakumar TM, Sirisha GBN, Farzana Begam MD, Dhanaraju MD. Mechanism Linking Cognitive Impairment and Diabetes mellitus. Europ J Appl Sci. 2012;4:1-10.

  8. Alagiakrishnan K, Zhao N, Mereu L, Senior P, Senthilselvan A. Montreal cognitive assessment is superior to standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Bio Med Research Int. 2013. http://dx.doi.org/10.1155/2013/186106.

  9. Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clinical Interv Aging. 2014;9:1011-9.

  10. Luchsinger JA. Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis. 2012;30:S185-98.

  11. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001;154:635-41.

  12. Peila R, Rodriguez BL, Launer LJ. Type 2 Diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia aging study. Diabetes. 2002;51:1256-62.

  13. Manschot SM, Brands AMA, van der Grond J, et al. On behalf of the Utrecht Diabetic Encephalopathy Study G. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55:1106-13.

  14. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.

  15. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care. 2006;29:1794-9.

  16. Hazari MAH, Reddy BR, Uzma N, Kumar BS. Cognitive impairment in type 2 diabetes mellitus. Int J Diab Mellitus. 2011.

  17. Polich J, Herbst KL. P300 as a clinical assay: rationale, evaluation, and findings. Int J Psychophysiol. 2000;38:3-19.

  18. Pozzessere G, Rizzo PA, Valle E, et al. Early detection of neurological involvement in IDDM and NIDDM multimodal evoked potentials versus metabolic control. Diabetes Care. 1988;11:473-80.

  19. Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV. Cognitive function in younger type II diabetes. Diabetes Care. 1997;20:32-5.

  20. Tandon OP, Verma A, Ram BK. Cognitive dysfunction in NIDDM: P3 event related evoked potential study. Indian J Physiol Pharmacol. 1999;43:383-8.

  21. Chen X, Chen W, Chen SR, Luo YP. Event-related potentials P300 in type 2 diabetes mellitus. Di Yi Jun Yi Da XueXueBao. 2003;23:257-9.

  22. Dolu H, Ulas UH, Bolu E, et al. Evaluation of central neuropathy in type II diabetes mellitus by multimodal evoked potentials. Acta Neurol Belg. 2003;103:206-11.

  23. Cosway R, Strachan MWJ, Dougall A, Frier BM, Deary IJ. Cognitive function and information processing in type 2 diabetes. Diabetic Med. 2001;18:803-10.

  24. Aminoff MJ. Use of somatosensory evoked potentials to evaluate the peripheral nervous system. J Clin Neurophysiol. 1987;4:135-44.

  25. Eisen A. The use of somatosensory evoked potentials for the evaluation of the peripheral nervous system. Neurol Clin. 1988;6:825-38.

  26. Constantinovici A. The diagnostic value of somatosensory evoked potentials in the diseases of peripheral nervous system. Neurol Psychiatr (Bucur). 1989;27:111-25.

  27. Nakamura Y, Takahashi M, Kitaguchi M, et al. Clinical utility of somatosensory evoked potentials in diabetes mellitus. Diabetes Res Clin Pract. 1989;7:17-23.

  28. Ziegler D, Muhlen H, Dannehl K, Gries FA. Tibial nerve somatosensory evoked potentials at various stages of peripheral neuropathy in insulin dependent diabetic patients. J Neurol Neurosur Ps. 1993;56:58-64.

  29. Nakamura R, Noritake M, Hosoda Y, Kamakura K, Nagata N, Shibasaki H. Somatosensory conduction delay in central and peripheral nervous system of diabetic patients. Diabetes Care. 1992;15:532-5.

  30. Fierro B, Meli F, Brighina F, et al. Somatosensory and visual evoked potentials study in young insulin-dependent diabetic patients. Electromyogr Clin Neurophysiol. 1996;36:481-6.

  31. Näätänen R, Picton T. The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology. 1987;24:375-425.

  32. Johnson A, Yonovitz A. Habituation of auditory evoked potentials: the dynamics of waveform morphology. Aust N Z J Audiol. 2007; 29:77-88.

  33. Hernández OH, García-Martínez R, Monteón V. The relationship between parameters of long-latency brain potentials in a multisensory design: evoked potentials. Clin EEG Neurosc. 2015.

  34. Hernández OH, García-Martínez R, Monteón V. Alcohol effects on the p2 component of auditory evoked potentials. An Acad Bras Cienc. 2014;86:437-49.

  35. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189-98.

  36. Umegaki H, Iimuro S, Kaneko T, et al. Factors associated with lower Mini Mental State Examination scores in elderly Japanese diabetes mellitus patients. Neurobiol Aging. 2008;29:1022-6.

  37. Alencar RC, Cobas RA, Gomes MB. Assessment of cognitive status in patients with type 2 diabetes through the mini-mental status examination: a cross-sectional study. Diabetol Metab Syndr. 2010;2:10. http://www. dmsjournal.com/content/2/1/10.

  38. Karan NS. Assessment of the cognitive status in diabetes mellitus. J Clin Diagn Res. 2012;6:1658-62.

  39. Molloy DW, Standish T. Mental status and neuropsychological assessment- A guide to the standardized Mini-Mental State Examination. Int Psychogeriatr. 1997;9:87-94.

  40. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination on the basis of the age and the educational level. JAMA. 1993;269:2386-91.

  41. Folstein MF, Folstein SE, McHugh PR, Fanjiang G. Mini-mental state examination user’s guide. Odessa, FL: Psychological Assessment Resources, 2001.

  42. Takeda M, Tachibana H, Sugita M, Hirayama H, Miyauchi M, Matsuoka A. Event-related potential in patients with diabetes mellitus. Rinsho Byori. 1992;40:896-900.

  43. Kurita A, Mochio S, Isogai Y. Changes in auditory P300 event related potentials and brainstem evoked potentials in diabetes mellitus. Acta Neurol Scand. 1995;92:319-23.

  44. Hissa MN, D’Almeida JAC, Cremasco F, Bruin VMS. Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes. Neuro Endocrinol Lett. 2002;23:226-30.

  45. Alvarenga K de F, Duarte JL, da Silva DPC, Agostinho Pesse RS, Negrato CA, Costa OA. Cognitive P300 potential in subjects with Diabetes Mellitus. Braz J Otorhinolaryngol. 2005;71:202-7.

  46. Andreadou E, Mitrakou A, Constantinides VC, Triantafyllou N. Auditory P300 event-related potentials in patients with type 2 diabetes mellitus. J Diabetes Res Clin Metabol. 2012. http://www.hoajonline.com/journals/ pdf/2050-0866-1-1.pdf.

  47. Hernández OH, García-Martínez R, Lizana-Henríquez C, et al. Tomografía de coherencia óptica y potenciales evocados visuales en pacientes con diabetes mellitus tipo 2 con y sin retinopatía: informe preliminar. Rev Invest Clin. 2014;66:330-8.

  48. Chopra D, Gupta M, Manchanda KC, Sarup Sharma R, Singh Sidhu R. A study of visual evoked potentials in patients of type-2 diabetes mellitus. J Clin Diagn Res. 2011;5:519-22.

  49. Heravian J, Ehyaei A, Shoeibi N, et al. Pattern visual evoked potentials in patients with type II diabetes mellitus. J Ophthalmic Vis Res. 2012;7:225-30.

  50. Puvanendran K, Devathasan G, Wong PK. Visual evoked responses in diabetes. J Neurol Neurosurg Psychiatry. 1983;46:643-7.

  51. Parisi V, Uccioli L, Monticone G, Parisi L, Menzinger G, Bucci MG. Visual evoked potentials after photostress in insulin-dependent diabetic patients with or without retinopathy. Graefe´s Arch Clin Exp Ophthalmol. 1994;232:193-8.

  52. Azal Ö, Özkardes A, Önde ME, et al. Visual evoked potentials in diabetic patients. Tr J Medic Sci. 1998;28:139-42.

  53. Gayathri V, Vijayalakshmi B, Chandrasekhar M. Electrophysiological assessment of neuropathy in visual pathway of diabetes mellitus. J Diabetol. 2012;1:4.

  54. Crowley KE, Colrain IM. A review of the evidence for P2 being an independent component process: age, sleep and modality. Clin Neurophysiol. 2004;115:732-44.

  55. Kwon SI, Hwang DJ, Seo JY, Park IW. Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery. Korean J Ophtalmol. 2011;25:238-42.

  56. Williamson JR, Kilo C. Pathogenetic mechanisms of diabetic microvascular disease. In Immunology in Diabetes. Andreani D, Di Mario U, Federlin KF, Heding LG, editores. London: Kimpton; 1984. p. 245-54.

  57. Williamson JR, Chang K, Tilton RG, Kilo C. Diabetic vascular disease: an integrated view. In Diabetic Complications: Early Diagnosis and Treatment. Andreani D, Crepaldi G, Di Mario U, Pozza G, editores. Chichester UK: Wiley; 1987. p. 213-7.

  58. Umegaki H. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration? Age Ageing. 2010;39:8-10.

  59. Bhanu R, Vinutha Shankar MS, Karthiyanee K, Nachal A. Visual evoked potentials in non insulin dependent diabetes mellitus without retinopathy: A pilot study. Curr Neurobiol. 2012;3:55-9.

  60. Bush AI, Tanzi RE. Therapeutics for Alzheimer´s disease based on the metal hypothesis. Neurotherapeutics. 2008;5:421-32.

  61. Tecchio F, Assenza G, Zappasodi F, Mariani S, Salustri C, Squitti R. Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasmin. Int J Alzheimer Dis. 2011.

  62. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999;10:1937-42.




2020     |     www.medigraphic.com